These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 12487756)
1. Hypocholesterolemic effect of spirulina in patients with hyperlipidemic nephrotic syndrome. Samuels R; Mani UV; Iyer UM; Nayak US J Med Food; 2002; 5(2):91-6. PubMed ID: 12487756 [TBL] [Abstract][Full Text] [Related]
2. Impact of fluvastatin on hyperlipidemia after renal transplantation. Tokumoto T; Tanabe K; Ishida H; Shimmura H; Ishikawa N; Goya N; Akiba T; Toma H Transplant Proc; 2004 Sep; 36(7):2141-4. PubMed ID: 15518777 [TBL] [Abstract][Full Text] [Related]
3. Anti-hypercholesterolemic effect of Pistacia lentiscus fatty oil in egg yolk-fed rabbits: a comparative study with simvastatin. Djerrou Z Chin J Nat Med; 2014 Aug; 12(8):561-6. PubMed ID: 25156280 [TBL] [Abstract][Full Text] [Related]
4. Effects of D-003, a mixture of long-chain aliphatic primary acids, fluvastatin and the combined therapy of D-003 plus fluvastatin on the lipid profile of normocholesterolemic rabbits. Mendoza S; Gamez R; Mas R; Goicochea E Int J Tissue React; 2003; 25(3):81-9. PubMed ID: 14756189 [TBL] [Abstract][Full Text] [Related]
5. The hyperlipidemia of the nephrotic syndrome. Relation to plasma albumin concentration, oncotic pressure, and viscosity. Appel GB; Blum CB; Chien S; Kunis CL; Appel AS N Engl J Med; 1985 Jun; 312(24):1544-8. PubMed ID: 3858668 [TBL] [Abstract][Full Text] [Related]
6. Hypolipidemic effect of fenugreek seeds and its comparison with atorvastatin on experimentally induced hyperlipidemia. Sharma MS; Choudhary PR J Coll Physicians Surg Pak; 2014 Aug; 24(8):539-42. PubMed ID: 25149829 [TBL] [Abstract][Full Text] [Related]
7. Long-term effect of lovastatin on lipoprotein profile in patients with primary nephrotic syndrome. Prata MM; Nogueira AC; Pinto JR; Correia AM; Vicente O; Rodrigues MC; Miguel MJ Clin Nephrol; 1994 May; 41(5):277-83. PubMed ID: 8050207 [TBL] [Abstract][Full Text] [Related]
8. The hypolipidaemic effects of Spirulina (Arthrospira platensis) supplementation in a Cretan population: a prospective study. Mazokopakis EE; Starakis IK; Papadomanolaki MG; Mavroeidi NG; Ganotakis ES J Sci Food Agric; 2014 Feb; 94(3):432-7. PubMed ID: 23754631 [TBL] [Abstract][Full Text] [Related]
9. Effects of lovastatin on hepatic expression of the low-density lipoprotein receptor in nephrotic rats. Wei LX; Chen L; Wang WM; Zhang XH; Wu JB; Liang SF; Shu GY Genet Mol Res; 2014 Feb; 13(1):938-44. PubMed ID: 24634114 [TBL] [Abstract][Full Text] [Related]
10. Lovastatin therapy in nephrotic hyperlipidemia: effects on lipoprotein metabolism. Vega GL; Grundy SM Kidney Int; 1988 Jun; 33(6):1160-8. PubMed ID: 3165483 [TBL] [Abstract][Full Text] [Related]
11. Oat-derived beta-glucan significantly improves HDLC and diminishes LDLC and non-HDL cholesterol in overweight individuals with mild hypercholesterolemia. Reyna-Villasmil N; Bermúdez-Pirela V; Mengual-Moreno E; Arias N; Cano-Ponce C; Leal-Gonzalez E; Souki A; Inglett GE; Israili ZH; Hernández-Hernández R; Valasco M; Arraiz N Am J Ther; 2007; 14(2):203-12. PubMed ID: 17414591 [TBL] [Abstract][Full Text] [Related]
12. Characteristics of lipid metabolism under different urinary protein excretion in children with primary nephrotic syndrome. Hu P; Lu L; Hu B; Du PF Scand J Clin Lab Invest; 2009; 69(6):680-6. PubMed ID: 19468931 [TBL] [Abstract][Full Text] [Related]
13. Cholesterol-lowering effect of concentrated pomegranate juice consumption in type II diabetic patients with hyperlipidemia. Esmaillzadeh A; Tahbaz F; Gaieni I; Alavi-Majd H; Azadbakht L Int J Vitam Nutr Res; 2006 May; 76(3):147-51. PubMed ID: 17048194 [TBL] [Abstract][Full Text] [Related]
14. Serum lipid profiles including non-high density lipoprotein cholesterol levels in Turkish school-children. Uçar B; Kiliç Z; Dinleyici EC; Colak O; Güneş E Anadolu Kardiyol Derg; 2007 Dec; 7(4):415-20. PubMed ID: 18065339 [TBL] [Abstract][Full Text] [Related]
15. Effect of combining viscous fibre with lovastatin on serum lipids in normal human subjects. Agrawal AR; Tandon M; Sharma PL Int J Clin Pract; 2007 Nov; 61(11):1812-8. PubMed ID: 17935545 [TBL] [Abstract][Full Text] [Related]
16. Hyperlipidemia in childhood idiopathic nephrotic syndrome during initial remission and relapse. Mahmud S; Jahan S; Hossain MM Mymensingh Med J; 2011 Jul; 20(3):402-6. PubMed ID: 21804502 [TBL] [Abstract][Full Text] [Related]
17. Comparison of the effects of simultaneous administration of vitamin C and omega-3 fatty acids on lipoproteins, apo A-I, apo B, and malondialdehyde in hyperlipidemic patients. Shidfar F; Keshavarz A; Jallali M; Miri R; Eshraghian M Int J Vitam Nutr Res; 2003 May; 73(3):163-70. PubMed ID: 12847992 [TBL] [Abstract][Full Text] [Related]
18. Long-term (18-month) efficacy of atorvastatin therapy in type 2 diabetics at cardiovascular risk. Velussi M Nutr Metab Cardiovasc Dis; 2002 Feb; 12(1):29-35. PubMed ID: 12125227 [TBL] [Abstract][Full Text] [Related]
19. Comparison of combined statin-fibrate treatment to monotherapy in patients with mixed hyperlipidemia. Kłosiewicz-Latoszek L; Szostak WB; Grzybowska B; Białobrzeska-Paluszkiewicz J; Wiśniewska B; Stolarska I Kardiol Pol; 2004 Jun; 60(6):567-77. PubMed ID: 15334157 [TBL] [Abstract][Full Text] [Related]
20. Correlates of serum lipids and lipoproteins in Congolese patients with arterial hypertension. Lepira FB; M'Buyamba-Kabangu JR; Kayembe KP; Nseka MN Cardiovasc J S Afr; 2005; 16(5):249-55. PubMed ID: 16307156 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]